Reference number : 236-2016-2017-Q1-00357, amendment number : , agreement type : G, recipient legal name : Leask, Andrew C, recipient country : CA, recipient province : ON, recipient city : London, recipient postal code : N6A 3K7, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 274797.0, agreement start date : 2016-04-01, agreement end date : 2019-03-31, description english : CCN3: a novel antifibrotic treatment?, description french : CCN3: a novel antifibrotic treatment?, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada